Day: October 16, 2025

Tackling the UK’s Obesity Epidemic: Why Scalable Platforms Are the Key to Change

Dr. Elena Torres, a London-based endocrinologist, partners with us: “Scalable platforms like Health45’s are game-changers for underserved patients.” Her insight highlights the real-world ripple effects.Conclusion and CTA
Addressing the obesity epidemic requires bold, scalable action. Be part of the solution—and the growth—with Health45.

The GLP-1 Revolution: How Breakthrough Weight-Loss Treatments Are Transforming Lives

Meet Sarah, a 42-year-old from Manchester who shed 25kg in six months via our platform. “It wasn’t just the meds; it was the support,” she shares. Stories like hers underscore the human impact—and the market potential.
The GLP-1 revolution isn’t just about weight loss; it’s about reclaiming health on a massive scale. Ready to invest in this transformative wave? As a High Net Worth or Sophisticated Investor, explore Health45’s private opportunities today. 

A private investment opportunity in two scalable health ventures: GLP-1 weight-loss platform and nutraceutical wellness.

Facebook-f Linkedin

Health45. Transforming Wellness Through Investment

Copyright © 2025 Health45. All Rights Reserved.

Exclusive Access for
Experienced Investors

This website presents information intended solely for those who possess the required expertise, resources, and professional standing to evaluate and engage with alternative investment opportunities. To proceed, you must confirm that you are a Sophisticated Investor, a High Net Worth Individual, or a regulated financial professional. If you do not meet one of these criteria, please do not continue.
By entering this site, you acknowledge the content is:

  • Directed only at individuals or entities deemed capable of understanding and assessing these offerings;
  • Not designed or intended for retail investors, who should refrain from further use;
  • Provided under exemptions allowed by applicable financial promotion rules.


Important Considerations
Investments described here are unregulated and thus carry the possibility of limited liquidity, reduced protections, and potential loss of capital. Our firm is not authorised by the Financial Conduct Authority (FCA), and no recourse to the Financial Services Compensation Scheme (FSCS) or the Financial Ombudsman Service is available. Any performance information or projections are for illustrative purposes only and do not guarantee future results. If you are uncertain about the suitability of these investment opportunities, you should consult an independent professional adviser.

The information on this website is intended for investment professionals and institutional investors only.
Investing involves risks, including potential loss of capital. This promotion is directed at eligible investors under the Financial Promotion Order—others should not rely on it. Past performance is not indicative of future results. This content is for informational purposes only and does not constitute investment, tax, or legal advice. Prospective investors should consult independent advisors. Health 45 is not authorised by the FCA. Information is provided under exemptions for high-net-worth, sophisticated, and professional investors, as defined in the UK Financial Services and Markets Act (Financial Promotion) Order.
COPYRIGHT © HEALTH45 2025